These brain-altering meds linked to falls and confusion are being prescribed to 25% of older adults with dementia

While all medications carry potential side effects, certain types have been shown to increase the risk of falls, confusion ...
McKnight's Long-Term Care News

One in four older Americans with dementia is prescribed high-risk CNS meds, study finds

About 25% of Medicare beneficiaries with dementia were prescribed high-risk central nervous system (CNS) – active medications associated with falls, confusion and hospitalizations between 2013 and ...
FierceBiotech

MapLight brightens SandboxAQ with new deal to discover new CNS candidates

MapLight Therapeutics is the latest biotech to want a turn with Alphabet’s AI spinout SandboxAQ. The neuro-focused company is penning a strategic collaboration meant to develop new therapies for ...
FierceBiotech

Lilly pulls out of CNS portion of $960M RIPK1 inhibitor collab with Rigel

Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...
PharmiWeb

Central Nervous System (CNS) Therapeutics Strategic Business Report 2025-2030 - Biologics, Gene Therapies, and Small Molecules Converge in Development Pipelines for CNS ...

DUBLIN--(BUSINESS WIRE)--The "Central Nervous System Therapeutics Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Central Nervous ...
Business Wire

Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi

- Portfolio available in 60+ markets and deepens our CNS footprint in Brazil, South Africa, France and Italy BASILDON, England--(BUSINESS WIRE)--PRESS RELEASE – FOR TRADE, BUSINESS AND MEDICAL MEDIA ...